Cargando…

Knockdown of MUC16 (CA125) Enhances the Migration and Invasion of Hepatocellular Carcinoma Cells

As an important global medical problem, hepatocellular carcinoma (HCC) has been recognized as the most frequent primary liver cancer and a leading cause of death among patients with cirrhosis. Surveillance of HCC using serum markers aims to reduce the disease-related mortality of HCC. MUC16 (mucin 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yao, Huang, Xiaoyu, Zeng, Jianxing, Lin, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208084/ https://www.ncbi.nlm.nih.gov/pubmed/34150633 http://dx.doi.org/10.3389/fonc.2021.667669

Ejemplares similares

CA125/MUC16 Is Dispensable for Mouse Development and Reproduction
por: Cheon, Dong-Joo, et al.
Publicado: (2009)

Knockdown of NDUFC1 inhibits cell proliferation, migration, and invasion of hepatocellular carcinoma
por: Han, Fang, et al.
Publicado: (2022)

Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion
por: Rao, Thapi D., et al.
Publicado: (2015)

Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in Relation to Ovarian Cancer Risk and Survival
por: Williams, Kristina A., et al.
Publicado: (2014)

Conflicting Views on the Molecular Structure of the Cancer Antigen CA125/MUC16
por: Bouanene, Houda, et al.
Publicado: (2010)

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
por: Felder, Mildred, et al.
Publicado: (2014)

Individual recombinant repeats of MUC16 display variable binding to CA125 antibodies
por: Wang, Chien-Wei, et al.
Publicado: (2023)

Prognostic Significance of Elevated Preoperative Serum CA125 Levels After Curative Hepatectomy for Hepatocellular Carcinoma
por: Huang, Yao, et al.
Publicado: (2020)

Expression of MUC16/CA125 Is Associated with Impaired Survival in Patients with Surgically Resected Cholangiocarcinoma
por: Kinzler, Maximilian N., et al.
Publicado: (2022)

Mesothelin Binding to CA125/MUC16 Promotes Pancreatic Cancer Cell Motility and Invasion via MMP-7 Activation
por: Chen, Shih-Hsun, et al.
Publicado: (2013)

The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity
por: Saad, Hebatallah M., et al.
Publicado: (2022)

MUC16/CA125 in the Context of Modular Proteins with an Annotated Role in Adhesion-Related Processes: In Silico Analysis
por: Jankovic, Miroslava, et al.
Publicado: (2012)

Integrin α7 knockdown suppresses cell proliferation, migration, invasion and EMT in hepatocellular carcinoma
por: Wu, Zhiyong, et al.
Publicado: (2021)

Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination
por: Huang, Chao, et al.
Publicado: (2019)

SERINC2-knockdown inhibits proliferation, migration and invasion in lung adenocarcinoma
por: Zeng, Yuan, et al.
Publicado: (2018)

Knockdown of Thymidine Kinase 1 Suppresses Cell Proliferation, Invasion, Migration, and Epithelial–Mesenchymal Transition in Thyroid Carcinoma Cells
por: Liu, Chang, et al.
Publicado: (2020)

Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei
por: Liang, Lei, et al.
Publicado: (2021)

Knockdown of Kremen2 Inhibits Tumor Growth and Migration in Gastric Cancer
por: Chen, Beibei, et al.
Publicado: (2021)

Knockdown of SOX18 inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells
por: WANG, GUIMING, et al.
Publicado: (2015)

HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy
por: Xiang, Xinran, et al.
Publicado: (2011)

Knockdown of TMEM16A suppressed MAPK and inhibited cell proliferation and migration in hepatocellular carcinoma
por: Deng, Liang, et al.
Publicado: (2016)

MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma
por: Chirravuri-Venkata, Ramakanth, et al.
Publicado: (2023)

Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients
por: Einama, Takahiro, et al.
Publicado: (2021)

Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells
por: Comamala, M, et al.
Publicado: (2011)

Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma
por: Zheng, Jia, et al.
Publicado: (2022)

Deep Learning of Liver Contrast-Enhanced Ultrasound to Predict Microvascular Invasion and Prognosis in Hepatocellular Carcinoma
por: Zhang, Yafang, et al.
Publicado: (2022)

ABCC6 Knockdown Fuels Cell Proliferation by Regulating PPARα in Hepatocellular Carcinoma
por: Zhao, Zhicong, et al.
Publicado: (2022)

Knockdown of FBI-1 Inhibits the Warburg Effect and Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeted Agents via miR-3692/HIF-1α
por: Liu, Juan, et al.
Publicado: (2021)

MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression
por: Matte, Isabelle, et al.
Publicado: (2014)

High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring MUC16/CA125 mutations
por: Wang, Qinghua, et al.
Publicado: (2020)

Epirubicin Enhances the Anti-Cancer Effects of Radioactive (125)I Seeds in Hepatocellular Carcinoma via Downregulation of the JAK/STAT1 Pathway
por: Guo, Lei, et al.
Publicado: (2022)

Non-invasive preoperative prediction of Edmondson-Steiner grade of hepatocellular carcinoma based on contrast-enhanced ultrasound using ensemble learning
por: Wang, Yao, et al.
Publicado: (2023)

Pre- and Postoperative Models for Prediction of Recurrence in Non-B, Non-C Hepatocellular Carcinoma
por: Lin, Kongying, et al.
Publicado: (2021)

Medication for Acromegaly Reduces Expression of MUC16, MACC1 and GRHL2 in Pituitary Neuroendocrine Tumour Tissue
por: Saksis, Rihards, et al.
Publicado: (2021)

Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib vs. (125)Iodine Implantation
por: Hu, Hong-Tao, et al.
Publicado: (2021)

Revisiting Surgical Strategies for Hepatocellular Carcinoma With Microvascular Invasion
por: Zhang, Er-lei, et al.
Publicado: (2021)

Characterization of the tumor marker muc16 (ca125) expressed by murine ovarian tumor cell lines and identification of a panel of cross-reactive monoclonal antibodies
por: Goodell, Cara AR, et al.
Publicado: (2009)

Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκB
por: Morgado, Micaela, et al.
Publicado: (2016)

Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies
por: Stasenko, Marina, et al.
Publicado: (2021)

Clinical Outcome of CT-Guided Iodine-125 Radioactive Seed Implantation for Intrahepatic Recurrent Hepatocellular Carcinoma: A Retrospective, Multicenter Study
por: Yuan, Qianqian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_krr9k6j2j77f25n6cfjhit8jcb